Back
VYNE Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62
VYNE
VYNE Therapeutics, Inc.
Last Price:
$0.57
Seasonality Move:
-5.82%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VYNE is experiencing buying pressure, which is a positive indicator for future bullish movement.
VYNE Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.53 | Buy |
| 20-day SMA: | 0.44 | Buy |
| 50-day SMA: | 0.39 | Buy |
| 200-day SMA: | 0.85 | Sell |
| 8-day EMA: | 0.45 | Buy |
| 20-day EMA: | 0.26 | Buy |
| 50-day EMA: | 0.12 | Buy |
| 200-day EMA: | 0.03 | Buy |
VYNE Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 73.62 | Buy |
| Chaikin Money Flow: | 884187 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.33 - 0.51) | Buy |
| Bollinger Bands (100): | (0.3 - 0.42) | Buy |
VYNE Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for VYNE Therapeutics, Inc. Stock
Is VYNE Therapeutics, Inc. Stock a Buy?
-
VYNE Therapeutics, Inc. share price is 0.58 while VYNE 8-day simple moving average is 0.53, which is a Buy signal.
-
The stock price of VYNE is 0.58 while VYNE Therapeutics, Inc. 20-day SMA is 0.44, which makes it a Buy.
-
VYNE Therapeutics, Inc. 50-day simple moving average is 0.39 while VYNE share price is 0.58, making it a Buy technically.
-
VYNE stock price is 0.58 and VYNE Therapeutics, Inc. 200-day simple moving average is 0.85, creating a Sell signal.
VYNE Technical Analysis vs Fundamental Analysis
Buy
62
VYNE Therapeutics, Inc. (VYNE)
is a Buy
Is VYNE Therapeutics, Inc. a Buy or a Sell?
-
VYNE Therapeutics, Inc. stock is rated a BuyThe current VYNE Therapeutics, Inc. [VYNE] share price is $0.58. The Score for VYNE is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
VYNE Therapeutics, Inc. Stock Info
Market Cap:
19.4M
Price in USD:
0.58
Share Volume:
957.9K
VYNE Therapeutics, Inc. 52-Week Range
52-Week High:
4.30
52-Week Low:
0.28
Buy
62
VYNE Therapeutics, Inc. (VYNE)
is a Buy
VYNE Therapeutics, Inc. Share Price Forecast
-
What is the VYNE Therapeutics, Inc. stock price today?The VYNE Therapeutics, Inc. stock price is 0.58 USD today.
-
Will VYNE stock go up or go down?VYNE Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is VYNE Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, VYNE Therapeutics, Inc. is not overvalued.
Is VYNE Therapeutics, Inc. Stock a Buy?
-
VYNE Therapeutics, Inc. share price is 0.58 while VYNE 8-day exponential moving average is 0.45, which is a Buy signal.
-
The stock price of VYNE is 0.58 while VYNE Therapeutics, Inc. 20-day EMA is 0.26, which makes it a Buy.
-
VYNE Therapeutics, Inc. 50-day exponential moving average is 0.12 while VYNE share price is 0.58, making it a Buy technically.
-
VYNE stock price is 0.58 and VYNE Therapeutics, Inc. 200-day simple moving average is 0.03, creating a Buy signal.
Fundamental Analysis of VYNE Therapeutics, Inc.
Is VYNE Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.36 per share, and a decrease next year of $0.21 per share.
Technical Analysis of VYNE Therapeutics, Inc.
Should I short VYNE Therapeutics, Inc. stock?
-
VYNE Moving Average Covergence Divergence (MACD) indicator is 0.15, suggesting VYNE Therapeutics, Inc. is a Buy
-
VYNE Therapeutics, Inc. Relative Strength Index (RSI) is 73.62, which suggest VYNE Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for VYNE Therapeutics, Inc. is (0.33 - 0.51), which suggest VYNE Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for VYNE Therapeutics, Inc. is (0.3 - 0.42), which suggest VYNE Therapeutics, Inc. is a Buy
* VYNE Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.